{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-26-004268","form_type":"8-K","ticker":"ACTU","cik":"0001652935","company_name":"ACTUATE THERAPEUTICS, INC.","filed_at":"2026-05-22T20:43:53+00:00","discovered_at":"2026-05-22T20:45:01.391830+00:00","generated_at":"2026-05-22T20:51:58.251881+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"confidence":"high","headline":"Actuate Therapeutics holds 2026 Annual Meeting; elects Fletcher and Keyes as directors, ratifies Crowe LLP as auditor","bullets":["Elected Aaron G.L. Fletcher, Ph.D. and Jason Keyes as Class II directors for three-year terms through 2029.","Fletcher received 14,877,247 for, 1,883,025 withheld; Keyes received 16,727,875 for, 32,397 withheld.","Ratified Crowe LLP as independent auditor for FY 2026 with 18,571,817 for, 50,023 against, 9,741 abstain.","Broker non-votes: 1,871,309 on director elections; none on auditor ratification."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-26-004268","json":"https://secwatch.observer/filing/0001683168-26-004268.json","markdown":"https://secwatch.observer/filing/0001683168-26-004268.md","text":"https://secwatch.observer/filing/0001683168-26-004268.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1652935/000168316826004268/0001683168-26-004268-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1652935/000168316826004268/actuate_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T20:51:58.251881+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}